Publications-ELK Biotechnology CO.,Ltd.

Technical

IF：18.5 Date：2025-05-13

ADVANCED FUNCTIONAL MATERIALS

Inhibiting Chemotherapy Immune Tolerance and Reversing Tumor Microenvironment by Macrophage-Targeted Nanohybrid Systems for Enhancing Tumor Chemo-Immunotherapy

Products： ELK1387
IF：17.4 Date：2023-10-01

Nano Today

Gemcitabine nano-prodrug reprograms intratumoral metabolism and alleviates immunosuppression for hepatocellular carcinoma therapy

Products： ELK1387
IF：17.4 Date：2024-01-03

ACS Nano

Engineered Biomimetic Nanovesicles Based on Neutrophils for Hierarchical Targeting Therapy of Acute Respiratory Distress Syndrome

Products： ELK0494
IF：16.7 Date：2025-02-18

NUCLEIC ACIDS RESEARCH

Direct repeat region 3′ end modifications regulate Cas12a activity and expand its applications

Products： ELK1301

< Page of 331 >